[go: up one dir, main page]

TR201815617A2 - Deksketoprofen içeren bir formülasyon. - Google Patents

Deksketoprofen içeren bir formülasyon. Download PDF

Info

Publication number
TR201815617A2
TR201815617A2 TR2018/15617A TR201815617A TR201815617A2 TR 201815617 A2 TR201815617 A2 TR 201815617A2 TR 2018/15617 A TR2018/15617 A TR 2018/15617A TR 201815617 A TR201815617 A TR 201815617A TR 201815617 A2 TR201815617 A2 TR 201815617A2
Authority
TR
Turkey
Prior art keywords
formulation containing
containing dexketoprofen
dexketoprofen
pain
pharmaceutically acceptable
Prior art date
Application number
TR2018/15617A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi filed Critical Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority to PCT/TR2018/000136 priority Critical patent/WO2020022976A2/en
Publication of TR201815617A2 publication Critical patent/TR201815617A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu buluş, özellikle kas-iskelet sistemi ağrıları olmak üzere uzun süren ağrı tedavisinde kullanılan, etkin madde olarak deksketoprofen serbest bazı veya farmasötik olarak kabul edilebilir bir tuzunu içeren, sürekli salım yapan tablet formunda olan bir farmasötik bileşim ile ilgilidir.
TR2018/15617A 2017-12-29 2018-10-19 Deksketoprofen içeren bir formülasyon. TR201815617A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/TR2018/000136 WO2020022976A2 (en) 2017-12-29 2018-12-28 A formulation comprising dexketoprofen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/23035A TR201723035A2 (tr) 2017-12-29 2017-12-29 Geciktirilmiş salınımlı deksketoprofen bileşimi.

Publications (1)

Publication Number Publication Date
TR201815617A2 true TR201815617A2 (tr) 2019-07-22

Family

ID=67900930

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2017/23035A TR201723035A2 (tr) 2017-12-29 2017-12-29 Geciktirilmiş salınımlı deksketoprofen bileşimi.
TR2018/15617A TR201815617A2 (tr) 2017-12-29 2018-10-19 Deksketoprofen içeren bir formülasyon.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2017/23035A TR201723035A2 (tr) 2017-12-29 2017-12-29 Geciktirilmiş salınımlı deksketoprofen bileşimi.

Country Status (2)

Country Link
TR (2) TR201723035A2 (tr)
WO (2) WO2019212426A2 (tr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115607509A (zh) * 2022-10-11 2023-01-17 南京正科医药股份有限公司 一种右旋酮洛芬氨丁三醇注射液及其制备工艺

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230414545A1 (en) * 2020-12-04 2023-12-28 Laboratorios Silanes S.A. De C.V. Fixed combination medicine for the control and management of neuropathic pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101623280A (zh) * 2008-07-10 2010-01-13 广东肇庆星湖生物科技股份有限公司 一种镇痛的复方缓释制剂及其制备方法
TR201104864A2 (tr) * 2011-05-18 2012-12-21 B�Lg�� Mahmut Deksketoprofen içeren suda çözünebilir formülasyonlar.
CN102813638A (zh) * 2011-06-07 2012-12-12 贵阳医学院 一种右旋酮洛芬氨丁三醇双层缓释片的制备方法
ES2394888B1 (es) * 2011-06-15 2013-09-23 Farmalider, S.A. Forma farmacéutica de liberación modificada de dexketoprofeno e inhibidor de la bomba de protones y uso de la misma.
WO2013022410A2 (en) * 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
WO2013095315A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Formulations comprising dexketoprofen (particle size 300-2500 micrometer)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115607509A (zh) * 2022-10-11 2023-01-17 南京正科医药股份有限公司 一种右旋酮洛芬氨丁三醇注射液及其制备工艺
CN115607509B (zh) * 2022-10-11 2024-01-30 南京正科医药股份有限公司 一种右旋酮洛芬氨丁三醇注射液及其制备工艺

Also Published As

Publication number Publication date
WO2020022976A2 (en) 2020-01-30
TR201723035A2 (tr) 2019-07-22
WO2020022976A3 (en) 2020-03-12
WO2019212426A3 (en) 2019-11-28
WO2019212426A2 (en) 2019-11-07

Similar Documents

Publication Publication Date Title
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
PH12017500281A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2021000550A (es) Forma de dosis orales de liberacion sostenida de tofacitinib.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
EA202090860A1 (ru) Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn
PH12016500420A1 (en) Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
CY1115556T1 (el) Φαρμακευτικη συνθεση για χορηγηση απο το στομα η οποια περιλαμβανει ετεξιλικη δαβιγατρανη
PH12015502632A1 (en) Cxcr7 receptor modulators
MX2016004934A (es) Derivados de aminotetralina y aminoindano, composiciones farmaceuticas que los contienen, y su uso en terapia.
EA201691741A1 (ru) Фармацевтическая композиция
MX2016001422A (es) Composicion farmaceutica de fingolimod.
EA201692298A1 (ru) Производные карбоксамидов
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
TR201815617A2 (tr) Deksketoprofen içeren bir formülasyon.
MX391191B (es) Composiciones de liberación extendida de onapristona y métodos.
EA201500446A1 (ru) Фармацевтическая композиция для снижения уровня n-оксида триметиламина
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
EA201990162A1 (ru) Фармацевтические композиции
EA201500366A1 (ru) Применение 1-адамантилетилокси-3-морфолино-2-пропанола или его фармацевтически приемлемых солей в фармацевтических композициях в качестве нейроретинопротектора
PH12020550597A1 (en) Formulation having improved hygroscopic property and dissolution rate comprising telmisartan or its pharmaceutically acceptable salt